Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/Cardiac Imaging Scores (ECHO, CT, MRI)
Interactive worksheet2 clinical inputsPatient data not stored

LGE Extent (% Myocardium Scarred) Calculator

LGE Extent (% Myocardium Scarred): Explanation and Clinical Context LGE (Late Gadolinium Enhancement) imaging by cardiac MRI allows quantification of myocardial scar tissue, expressed as a percentage of total left ventricular (LV) myocardial mass. The LGE extent is calculated as (Scar Mass / Total LV Myocardial Mass) × 100. Low values (0–5%) represent minimal or no fibrosis, while higher percentages indicate signific

Interactive worksheet

Clinical inputs

0/2 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

LGE Extent (% Myocardium Scarred): Explanation and Clinical Context LGE (Late Gadolinium Enhancement) imaging by cardiac MRI allows quantification of myocardial scar tissue, expressed as a percentage of total left ventricular (LV) myocardial mass. The LGE extent is calculated as (Scar Mass / Total LV Myocardial Mass) × 100. Low values (0–5%) represent minimal or no fibrosis, while higher percentages indicate significant myocardial scarring.

Clinically, LGE extent correlates with adverse cardiovascular outcomes, including arrhythmias, heart failure progression, and mortality risk. Patients with LGE >15% of LV mass are at higher risk for major adverse cardiac events (MACE) and may benefit from closer monitoring or device therapy. This tool provides a rapid, quantitative assessment for clinicians to stratify risk and guide management decisions.

Evidence & references1 primary source mapped
  1. Source 1

    Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 1999;343:1445–1453. doi:10.1056/NEJM199911183432003

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

e’ Average Calculator

Cardiac Imaging Scores (ECHO, CT, MRI)
Formula reviewed

E/e’ Average Calculator

Cardiac Imaging Scores (ECHO, CT, MRI)
Interactive worksheet

Peguero-Lo Presti Index Calculator

Cardiac Imaging Scores (ECHO, CT, MRI)
Interactive worksheet

RV Fractional Area Change (FAC) Calculator

Cardiac Imaging Scores (ECHO, CT, MRI)
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.